Thymosin Beta-4 vs Thymulin
How Thymosin Beta-4 and Thymulin compare — what each is, how strong the human evidence is for each, doses reported in research, the key risks, and 2026 US legal status. No universal winner.
Thymosin Beta-4 and Thymulin come up together when people are weighing similar options. Here's the honest side-by-side: what each is, how strong the human evidence is for each, the doses reported in research, the risks, and where each stands with the FDA as of 2026. There's no universal winner — scroll to the by-goal picks for which one fits which goal.
Thymosin Beta-4 vs Thymulin, point by point
Every dimension side by side — the honest differences, not a scoreboard.
| Dimension | Thymosin Beta-4 | Thymulin |
|---|---|---|
| What it is | Naturally occurring 43-amino-acid actin-sequestering peptide (thymosin β4) | Endogenous zinc-dependent nonapeptide thymic hormone (a 9-amino-acid signaling peptide secreted by the thymus) |
| Class / category | Healing / recovery | Immune / antimicrobial |
| Evidence tier | Animal-only · Unclear · none in humans | Human observational · Mixed |
| Studied / approved for | Dry eye disease / ocular surface repair (topical); Neurotrophic keratitis (topical); Cardiac repair after heart attack; Dermal wound healing (pressure & venous ulcers); Soft-tissue and musculoskeletal recovery | Immune support / immunomodulation; Age-related immune decline (immunosenescence); Anti-inflammatory and analgesic signaling; Neuroendocrine–immune modulation |
| US regulatory status (2026) | research use only (as of Jul 2026) | research use only (as of Jul 2026) |
| Doses reported in research | No established study doses | No established study doses |
| Registered trials (ClinicalTrials.gov) | 18 | 0 |
| Banned in sport (WADA) | Yes — on the WADA prohibited list | Yes — on the WADA prohibited list |
| Key risks | Thymosin beta-4 was generally well tolerated in the small completed human trials (topical eye drops and early systemic studies), with no major safety signal reported — but those trials were small and short, and there is no long-term human safety data for the muscle-recovery use people inject it for. The most-discussed theoretical concern is the flip side of its mechanism: a peptide that drives cell migration and new blood-vessel growth raises the reasonable, unproven question of whether it could feed something you would not want to grow. | Thymulin is a hormone the body already makes, which is reassuring in principle, but that does not make injecting extra thymulin automatically safe — human safety data are limited and mostly come from older, small clinical studies rather than modern trials, and there is no long-term safety data for the research-market use. The bigger practical risk is the source: thymulin is sold only as an unregulated research chemical, and an unregulated vial's purity, dose, and sterility are only as trustworthy as a seller no one is auditing. |
- Evidence tier: A tier reflects how human the evidence is, not a promise the compound works.
Thymosin Beta-4 vs Thymulin: the two molecules
The 2D chemical structures, straight from PubChem — a quick way to see how similar (or not) the two actually are.
Which one fits which goal?
There's no universal winner here — the honest answer depends on what you're after. These picks are framed by goal, and each says why.
If you want the option with more human evidence behind it
Leans toward Thymulin
Thymulin's evidence sits at human observational, a more human tier than Thymosin Beta-4's animal-only. That reflects how the data was gathered, not a guarantee it works.
References
- 1.Thymosin beta-4 — indexed research (PubMed, National Library of Medicine)
- 2.Thymosin beta-4 — registered clinical studies (ClinicalTrials.gov)
- 3.RGN-259 (thymosin beta-4) dry-eye Phase 3 trial ARISE-3 (ClinicalTrials.gov NCT03937882)
- 4.FDA — Drugs (approval status lookup)
- 5.USADA — Prohibited List (peptide hormones & growth factors)
- 6.Thymulin — indexed research (PubMed, National Library of Medicine)